We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has released a new supplement to the Orange Book list of “Approved Drug Products With Therapeutic Equivalence Evaluations,” a compendium that lists prescription drug products with therapeutic equivalence evaluations; over-the-counter drug products that require approved applications as a condition of marketing; approved drug products administered by the Center for Biologics Evaluation and Research; and products that have never been marketed, are for export, have been discontinued from marketing or that have had their approvals withdrawn for reasons other than safety or efficacy.